menu
    • menu

    Company profile for Savara

    NEW Drugs in Dev: 7
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex, AeroVanc and amikacin/fosfomycin. Molgradex is an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for autoimmune pulmonary alveolar proteinosis, or aPAP, and in Phase 2a development for nontuberculous mycobacteria, or NTM, in both non-cystic fibrosis (CF) and CF-affected individuals with chronic NTM lu...
    Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex, AeroVanc and amikacin/fosfomycin. Molgradex is an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for autoimmune pulmonary alveolar proteinosis, or aPAP, and in Phase 2a development for nontuberculous mycobacteria, or NTM, in both non-cystic fibrosis (CF) and CF-affected individuals with chronic NTM lung infection. AeroVanc, is a Phase 3 stage inhaled vancomycin for treatment of persistent methicillin-resistant Sstaphylococcus aureus, or MRSA, lung infection in CF.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SavaraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Savara Inc. 6836 Bee Cave Road, Building 3, Suite 200 Austin, TX, 78746
    Telephone
    Telephone
    +1 (512) 614-1848
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://savarapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/savara-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/SavaraPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Savara to Present at Jefferies Global Healthcare Conference
    Savara to Present at Jefferies Global Healthcare Conference

    27 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260527034505/en/Savara-Announces-Participation-in-the-2026-Jefferies-Global-Healthcare-Conference

    BUSINESSWIRE
    27 May 2026
    Share Share
    Savara Presents IMPALA-2 Biomarker Data on Molgramostim at ATS
    Savara Presents IMPALA-2 Biomarker Data on Molgramostim at ATS

    20 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260520792505/en/Savara-Presented-New-Biomarker-Data-from-the-IMPALA-2-Phase-3-Clinical-Trial-of-Molgramostim-Inhalation-Solution-Molgramostim-in-Autoimmune-Pulmonary-Alveolar-Proteinosis-aPAP-at-the-American-Thoracic-Society-ATS-International-Conference-2026

    BUSINESSWIRE
    20 May 2026
    Share Share
    Savara Presents Long-Term IMPALA-2 OL Extension Data in aPAP
    Savara Presents Long-Term IMPALA-2 OL Extension Data in aPAP

    19 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260519029544/en/Savara-Presented-Long-Term-Efficacy-and-Safety-Data-from-the-Ongoing-IMPALA-2-Phase-3-Clinical-Trial-Open-Label-OL-Extension-of-Molgramostim-Inhalation-Solution-Molgramostim-in-Autoimmune-Pulmonary-Alveolar-Proteinosis-aPAP

    BUSINESSWIRE
    19 May 2026
    Share Share
    Savara Shares New Exercise Capacity Data from IMPALA-2 Trial
    Savara Shares New Exercise Capacity Data from IMPALA-2 Trial

    18 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260518925976/en/Savara-Announces-New-Exercise-Capacity-Data-from-the-IMPALA-2-Phase-3-Clinical-Trial-of-Molgramostim-Inhalation-Solution-Molgramostim-in-Autoimmune-Pulmonary-Alveolar-Proteinosis-aPAP

    BUSINESSWIRE
    18 May 2026
    Share Share
    Savara Reports Q1 2026 Financial Results and Business Update
    Savara Reports Q1 2026 Financial Results and Business Update

    12 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260512677993/en/Savara-Reports-First-Quarter-Financial-Results-and-Provides-Business-Update

    BUSINESSWIRE
    12 May 2026
    Share Share
    Savara to Present at H.C. Wainwright BioConnect Conference
    Savara to Present at H.C. Wainwright BioConnect Conference

    11 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260511376114/en/Savara-Announces-Participation-in-the-H.C.-Wainwright-Co.-4th-Annual-BioConnect-Investor-Conference

    BUSINESSWIRE
    11 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search